Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis

QJM: An International Journal of Medicine

Volumn 104, Issue 11, 2011, Pages 971-979

  Harknett, E C ^a   Chang, W Y C ^a   Byrnes, S ^b   Johnson, J ^c   Lazor, R ^d,e,f   Cohen, M M ^g   Gray, B ^h   Geiling, S ⁱ   Telford, H ^j   Tattersfield, A E ^a   Hubbard, R B ^a   Johnson, S R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b The LAM Foundation   (United States)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITÉ LYON 1   (France)

^f Swiss Group for Interstitial and Orphan Lung Diseases   (Switzerland)

^g LAM Canada   (Canada)

^h The New Zealand LAM Charitable Trust   (New Zealand)

ⁱ LAM Selbsthilfe Deutschland eV   (Germany)

^j LAM Australasia Research Alliance   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; DISEASE REGISTRY; FEMALE; HEALTH INSURANCE; HUMAN; INCIDENCE; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; NEW ZEALAND; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND; UNITED KINGDOM; UNITED STATES;

EID: 80052809739     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr116     Document Type: Article

References (28)

1. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006; 27:1056-65.
2. Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998; 114:1689-703.
3. Ryu JH, Moss J, Beck GJ, Lee J-C, Brown KK, Chapman JT, et al. The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006; 173:105-11.
4. Taveira-DaSilva AM, Hedin C, Stylianou MP, Travis WD, Matsui K, Ferrans VJ, et al. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2001; 164:1072-6.
5. Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990; 323:1254-60.
6. Castro M, Shepherd CW, Gomez MR, Lie JT, Ryu JH. Pulmonary tuberous sclerosis. Chest 1995; 107:189-95.
7. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000; 97:6085-90.
8. Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, et al. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 2002; 47:20-8.
9. Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1999; 78:321-37.
10. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55:1052-7.
11. Carrington CB, Cugell DW, Gaensler EA, Marks A, Redding RA, Schaaf JT, et al. Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations. Am Rev Respir Dis 1977; 116:977-95.
12. McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest 2008; 133:507-16.
13. Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54:254-64.
14. Griggs R, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, et al. Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab 2009; 96:20-6.
15. The Swiss Statistics Web site. Federal Statistical Office. Neuchatel 2009. [http://www.bfs.admin.ch/bfs/portal/en/index.html] accessed July 2009.
16. German Federal Statistical Office. Wiesbaden 2008. [http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Navigation/Homepage__NT.psml)] accessed July 2009.
17. Annual Estimates of the Resident Population by Sex and Five-Year Age Groups for the United States (NC-EST2009-01): U.S. Census Bureau. Washington (2009), [http://www.census.gov/popest/national/asrh/NC-EST2009-sa.html] Accessed 2009.
18. Province and territory Statistics Canada. Population by marital status and sex. Province and territory Statistics Canada, Ottawa, (2009), CANSIM, [http://www40.statcan.ca/l01/cst01/famil01a-eng.htm] Accessed July 2009.
19. Quick Stats About a Place. Statistics New Zealand. (2006), [http://www.stats.govt.nz/Census/2006CensusHomePage/QuickStats.aspx] Accessed July 2009.
20. Australian Bureau of Statistics, Themes: Ageing (2004) [http://www.censusdata.abs.gov.au] Accessed July 2009.
21. Office for National Statistics. Census 2001. Office for National Statistics. [http://www.statistics.gov.uk/census2001/access_results.asp] Accessed July 2009.
22. U.S. Census Bureau. (2008) Health insurance coverage status by state for all people. U.S. Census Bureau, [http://www.census.gov/hhes/www/cpstables/032009/health/h06_000.htm] Accessed July 2009.
23. Central Intelligence Agency. Distribution of family income -Gini index. Central Intelligence Agency. [https://www.cia.gov/library/publications/the-world-factbook/] Accessed July 2009.
24. Johnson SR, Whale CI, Hubbard RB, Lewis SA, Tattersfield AE. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 2004; 59:800-3.
25. Schiavina M, Contini P, Fabiani A, Cinelli F, Di Scioscio V, Zompatori M, et al. Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients. Sarcoidosis Vasc Diffuse Lung Dis 2007; 24:39-50.
26. Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010; 35:14-26.
27. O'Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 1998; 351:1490.
28. Wiederholt W, Gomez M, Kurland L. Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982. Neurology 1985; 35:600-3.